Valuation dashboard for High Tide Inc. (HITI) with P/E N/A, P/B 3.76, EV/EBITDA -142.14 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
High Tide Inc. primarily operates as a prominent cannabis retailer with a significant presence across Canada, Europe, the United States, and other international markets. Beyond its retail footprint, the company is actively involved in the design, manufacturing, and distribution of smoking accessories and a variety of cannabis lifestyle products.
Analysis Summary
High Tide Inc. reported revenue of $594.0M in the most recent fiscal year, growing at a 5-year CAGR of 48.1%.
Trailing-twelve-month margins: gross margin 17.5%, operating margin 3.3%, net margin -6.6%.
At the current price of $2.69, HITI has negative trailing earnings (P/E not meaningful) and an ROE of -43.38%. Market capitalisation stands at $236M.
Balance sheet quality for HITI: current ratio of 1.4. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 3.76 |
| EV / EBITDA | -142.14 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $7.23 |
| vs Current Price | +168.6% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| HITI | High Tide Inc. | $236M | 3.76 | -43.4% | |
| RPRX | Royalty Pharma plc | $26.0B | 24.39 | 3.83 | |
| CORT | Corcept Therapeutics Incorporated | $12.1B | 207.35 | 16.10 | 8.4% |
| 0I3Q.L | Corcept Therapeutics Incorporated | $11.7B | 217.89 | 16.92 | 8.4% |
| LQDA | Liquidia Corporation | $5.8B | 43.62 | 31.18 | 149.6% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $5.8B | 70.23 | 8.91 | 13.7% |
| 0HF9.L | Amicus Therapeutics, Inc. | $5.3B | |||
| PBH | Prestige Consumer Healthcare Inc. | $2.2B | 13.05 | 1.16 |
Price
| Price | $2.69 |
| Market Cap | $236M |
| Exchange | NASDAQ |
| Country | CA |
Profitability
| Return on Equity | -43.38% |
| Return on Invested Capital | 8.00% |
| Return on Assets | -12.66% |
| Gross Margin | 17.52% |
| Operating Margin | 3.29% |
| Net Margin | -6.56% |
Related companies: CVRX · IMMP · LFMD · OMI · SENS · SGHT · SMTI
Explore sector: Healthcare · Medical - Pharmaceuticals
More sections of HITI: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks